The contribution of life events to schizophrenic relapse. An event history analysis

Hirsch, Steven R.; Emami, Javad; Bowen, Joanna; Cramer, P.

doi:10.1016/0920-9964(92)90278-d

Schizophrenia Research

1992

DOI: 10.1016/0920-9964(92)90278-d

|View full text |Cite

The contribution of life events to schizophrenic relapse. An event history analysis

Steven R. Hirsch

Javad Emami

Joanna Bowen

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…he goals of treatment with antipsychotic medication in schizophrenia are to reduce or eliminate symptoms, maximize patient functioning, and maintain recovery over the long term. 1 However, poor medication adherence (as traditionally measured) contributes to negative treatment response, 2 symptom relapse, 3,4 and hospitalization. 5 Relapse rates may be up to 5 times higher in patients who discontinue their antipsychotic medication than in those who continue treatment.…”

mentioning

confidence: 99%

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia

MacEwan¹,

Forma

Shafrin³

et al. 2016

JMCP

View full text Add to dashboard Cite

Otsuka Pharmaceutical Development & Commercialization provided support for this research. MacEwan and Shafrin are employees of Precision Health Economics, which was contracted by Otsuka Pharmaceutical Development & Commercialization to conduct this study. Lakdawalla is the Chief Scientific Officer and a founding partner of Precision Health Economics. Forma is an employee of Otsuka Pharmaceutical Development & Commercialization. Hatch is a former employee of Otsuka Pharmaceutical Development & Commercialization and is a current employee of ODH, Inc. Lindenmayer has received grant/research support from Janssen, Lilly, AstraZeneca, Johnson & Johnson, Pfizer, BMS, Otsuka, Dainippon, and Roche and is a consultant for Janssen, Lilly, Merck, Shire, and Lundbeck. Portions of this study were presented as a poster at the American Society of Clinical Psychopharmacology Annual Meeting in Miami Beach, Florida; June 23, 2015; and at the 28th Annual U.S. Psychiatric and Mental Health Congress; San Diego, California; September 12, 2015. Study concept and design were contributed by Forma, Ladkawalla, MacEwan, and Shafrin, along with Hatch and Lindenmayer. MacEwan, Shafrin, Forma, and Lakdawalla collected the data, along with Hatch and Lindenmayer. Data interpretation was performed by Hatch, Lindenmayer, MacEwan, and Shafrin, assisted by Forma and Lakdawalla. The manuscript was written and revised by MacEwan, Forma, and Shafrin, along with Hatch Lakdawalla, and Lindenmayer.

show abstract

mentioning

confidence: 99%

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia

MacEwan¹,

Forma

Shafrin³

et al. 2016

JMCP

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The contribution of life events to schizophrenic relapse. An event history analysis

Cited by 1 publication

References 0 publications

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia

Contact Info

Product

Resources

About